Bachem Holding (Suzhou): difference between revisions
Diff·revision 29 → 30·18:47, 15 Feb 2025
Difference between revision 29 and revision 30 of Bachem Holding (Suzhou). 10 lines changed; the page grew by 437 bytes.
| Revision 29 — 19:24, 8 Feb 2025 COA_Colwyn (talk) add figure 6,584 bytes ±0 | Revision 30 — 18:47, 15 Feb 2025 RfC_Rasmus (talk) add {{refimprove}}7,021 bytes +437 | ||
|---|---|---|---|
| 49 | Nothing in the catalogue distinguishes the organisation from its comparators. Its distinguishing features, such as they are, are the length of its registration history and the name coincidence.{{r|selfpub}} | 49 | Nothing in the catalogue distinguishes the organisation from its comparators. Its distinguishing features, such as they are, are the length of its registration history and the name coincidence.{{r|selfpub}} |
| 50 | 50 | ||
| + | 51 | == Independent testing record == | |
| + | 52 | Submitted reports on BCH material to July 2026 span the incretin range and a set of repair peptides. Reported [[Area percent purity|area percent]] figures have been high and consistent with the accompanying certificates where both are available.{{r|reports}} | |
| + | 53 | ||
| 51 | == References == | 54 | == References == |
| 52 | {{reflist}} | 55 | {{reflist}} |
| ⋮ | ⋮ | ||
| 57 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 60 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 58 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 61 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| + | 62 | ||
| + | 63 | == See also == | |
| + | 64 | * [[Certificate of analysis]] | |
| + | 65 | * [[Third-party testing]] | |
| + | 66 | * [[Area percent purity]] | |
| + | 67 | * [[Peptide content]] | |
| + | 68 | * [[Research use only]] | |
| 59 | 69 | ||
| 60 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} | 70 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} |